Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Till Hoffmann

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nature Communications|July 25, 2022
An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalenceMario Morvan, Anna Lo Jacomo, Celia Souque, et al.
Circulation Research|May 8, 2020
Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of Fxa-Driven Platelet Activation via Protease Activated Receptor-1"Tobias Petzold, Lisa Dannenberg, Manuela Thienel, et al.
Blood Advances|April 3, 2025
Platelet activating histone/antihistone IgG complexes in anti-PF4 negative thrombosis and thrombocytopenia syndromeMax Esefeld, Stefan Handtke, Rainer Kaiser, et al.
Blood|October 26, 2023
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposureLinda Schönborn, Olga Esteban, Jan Wesche, et al.
Circulation Research|April 10, 2020
Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1"Tobias Petzold, Manuela Thienel, Lisa Dannenberg, et al.
Circulation Research|December 21, 2019
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1Tobias Petzold, Manuela Thienel, Lisa Dannenberg, et al.
Journal of Hazardous Materials|October 16, 2021
Understanding and managing uncertainty and variability for wastewater monitoring beyond the pandemic: Lessons learned from the United Kingdom national COVID-19 surveillance programmesMatthew J Wade, Anna Lo Jacomo, Elena Armenise, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nature Communications|July 25, 2022
An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalenceMario Morvan, Anna Lo Jacomo, Celia Souque, et al.
Circulation Research|May 8, 2020
Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of Fxa-Driven Platelet Activation via Protease Activated Receptor-1"Tobias Petzold, Lisa Dannenberg, Manuela Thienel, et al.
Blood Advances|April 3, 2025
Platelet activating histone/antihistone IgG complexes in anti-PF4 negative thrombosis and thrombocytopenia syndromeMax Esefeld, Stefan Handtke, Rainer Kaiser, et al.
Blood|October 26, 2023
Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposureLinda Schönborn, Olga Esteban, Jan Wesche, et al.
Circulation Research|April 10, 2020
Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1"Tobias Petzold, Manuela Thienel, Lisa Dannenberg, et al.
Circulation Research|December 21, 2019
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1Tobias Petzold, Manuela Thienel, Lisa Dannenberg, et al.
Journal of Hazardous Materials|October 16, 2021
Understanding and managing uncertainty and variability for wastewater monitoring beyond the pandemic: Lessons learned from the United Kingdom national COVID-19 surveillance programmesMatthew J Wade, Anna Lo Jacomo, Elena Armenise, et al.
Pageof 4